ライフサイエンスコーパス: not significantly

1 ts who had received <15 doses (n=34), and -0.0135+/-0.1332 (not significantly different from 0; p=0.655) in those who had

2 o between the first and last MR study was -0.0275+/-0.1917 (not significantly different from 0; p=0.2968) in the entire g

3 nt from 0; p=0.2968) in the entire group, -0.0357+/-0.2204 (not significantly different from 0; p=0.351 in the patients w

4 Use of steroids was also not significantly associated with the number of courses of an

5 oxic as permethrin in four pyrethroid-resistant strains and not significantly less toxic than permethrin in a susceptible

6 y associated with SO2 (1.207 [1.154, 1.262; p < 0.001]) but not significantly associated with NO2 and PM10 (1.044 [0.998,

7 methylation (aOR, 6.49 [95% CI, 1.66-25.35], P = .007), but not significantly higher in women with positive anal methylat

8 impaired 7% (IQR = 0-19) after indomethacin (P = 0.04), but not significantly associated with reductions in MCAv(mean) (Y

9 Bempedoic acid did not significantly modify triglyceride level (MD -1.51%; 95% C

10 beta3 AR agonists did not significantly change heart rates or blood pressures.

11 Storage temperature (- 20 vs. - 80 degrees C) did not significantly affect the quantity of BDNF measured as mea

12 Measured aerosol concentration did not significantly increase with the use of either humidified

13 During simulations, the constriction did not significantly widen.

14 Clinical status on the ordinal outcome scale at 14 days did not significantly differ between the hydroxychloroquine and p

15 Ertugliflozin did not significantly reduce first HHF/CV death (hazard ratio [HR

16 Supplemental n-3 FAs did not significantly reduce the primary cardiovascular end point

17 Other DE measures did not significantly associate with CFU.

18 ted in non-responders and, more importantly, omalizumab did not significantly alter their expression levels.

19 Low-frequency rTMS to the right PPC did not significantly change measures of contrast sensitivity, bu

20 Panretinal photocoagulation rates did not significantly change among eyes with DME.

21 f 0.40 mg/kg, compared with 0.25 mg/kg, of tenecteplase did not significantly improve cerebral reperfusion prior to endov

22 We find that while the conformational changes do not significantly affect electron spin-spin distances, they d

23 Digital enhancements do not significantly improve radiographic detection of dental ca

24 ces T cell proliferation upon weak TCR stimulation but does not significantly affect phosphorylation of Zap70 (zeta chain

25 Further addition of water molecules does not significantly alter the observed hydrogen-bond topologies

26 Use of nonsterile gloves and an alcohol pad does not significantly impact the contamination of the rubber sept

27 ositive patients with a surveillance screening program does not significantly reduce ICU-acquired Pa infections in non-ou

28 SC-TNT does not significantly increase the risk of POM compared to CRT.

29 tical characterization showed that the inorganic lattice is not significantly perturbed even though the layer-to-layer sp

30 Cytotoxic chemotherapy administration was not significantly associated with a severe or critical COVID-

31 4.5 per 1000 women screened, respectively; P < .01) and was not significantly lower for repeat screening with FFDM (3.5 p

32 Prior use of ACEI/ARBs was not significantly associated with COVID-19 diagnosis among pa

33 e ARIC participants, IDH by the 2017 ACC/AHA definition was not significantly associated with incident ASCVD (n = 1386 ev

34 Arteriosclerosis (any degree) was not significantly associated with delayed graft function (OR,

35 MMP-9 in the CON group was not significantly changed [115.5(47.2) to 90.4(67.9);].

36 However, IDH was not significantly associated with increased risk for cardiova

37 that amorphous structure and morphology of the powders was not significantly influenced by oil addition.

38 By contrast, SOCE was not significantly different in TRPC1/6(-/-) pmLF and ROCE was

39 Time to stand was not significantly different between vamorolone-treated and co

40 in a simple unidimensional reinforcement-learning task was not significantly affected by age.

41 Restraint use was not significantly associated with resident's gender, dementia

42 erquartile range 17-62) in the ciprofloxacin arm, which was not significantly different (adjusted hazard ratio, 1.07; 95%

43 Demographic, laboratory and molecular characteristics were not significantly different between patients on the Beat AML

44 and experiences of musculoskeletal symptoms and injury were not significantly different by hospital characteristics.

45 The aggregation kinetics of insulin were not significantly affected in the presence of DMNDC, suggesti

46 roconversion rates, GMT and GMR, number of ILI or LCIs were not significantly different between arms.

47 or SUR2 (SUR2[STOP]) subunits, contractile parameters were not significantly different from those of WT vessels, suggest

48 TE derived strain, the RA reservoir and conduit strain were not significantly different between CMR-FT and the three echo

49 d cardiac valve calcium scores and pulse wave velocity were not significantly different among the treatment arms.

50 m) at baseline than those receiving ranibizumab, which were not significantly different.